Early Osteoarthritis 2021
DOI: 10.1007/978-3-030-79485-9_13
|View full text |Cite
|
Sign up to set email alerts
|

Mesenchymal Stromal Cells and Extracellular Vesicles

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1
1

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 186 publications
0
1
0
Order By: Relevance
“…Mesenchymal stromal cells (MSCs) are being widely investigated as regenerative therapies, and increasing evidence suggests MSCs can relieve symptoms of OA including pain and joint dysfunction, as well as preserve cartilage (15, 16). While the mechanisms governing the beneficial effects of implanted cells remain unclear, contemporary evidence indicates that MSCs act mainly by modulating the joint environment via their secreted products, which inhibit catabolic signaling pathways and promote anabolic responses (17).…”
Section: Introductionmentioning
confidence: 99%
“…Mesenchymal stromal cells (MSCs) are being widely investigated as regenerative therapies, and increasing evidence suggests MSCs can relieve symptoms of OA including pain and joint dysfunction, as well as preserve cartilage (15, 16). While the mechanisms governing the beneficial effects of implanted cells remain unclear, contemporary evidence indicates that MSCs act mainly by modulating the joint environment via their secreted products, which inhibit catabolic signaling pathways and promote anabolic responses (17).…”
Section: Introductionmentioning
confidence: 99%